Dacopafant

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameDacopafant

Drug Alias Name达考帕泛dacopafantumRP-55778

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet activating factor receptor antagonists

TargetsPlatelet activating factor receptor

Therapy Area/IndicationsSystemic Inflammatory Response SyndromeAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsSystemic Inflammatory Response SyndromeAsthma

ATC CodeN/A